{
  "ticker": "PAB",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959120",
  "id": "02959120",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250617",
  "time": "0935",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06ktgxk2pb2pfs.pdf",
  "summary": "- **Capital Raising Type**: Share issuance in lieu of cash payment (not a traditional capital raising)  \n- **Total Shares Issued**: 162,360,161 ordinary fully paid shares (code: PAB)  \n- **Issue Price**: Deemed price of $0.001 (0.1 cents) per share (AUD equivalent: ~$162,360)  \n- **Purpose**: Settlement of accrued salary and termination payments to Dr James Campbell (or nominee)  \n- **Key Condition**: Shareholder approval required (GM expected 21/7/2025)  \n- **Proposed Issue Date**: 28/7/2025  \n- **Material Dilution**: Represents significant issuance (~15% of pre-issue capital, assuming ~1.08bn shares outstanding) at a deep discount to market price (if applicable).  \n- **Ranking**: Equal to existing shares; no escrow/underwriting.  \n\n*Note: Not a capital raising for funding operations\u2014focus on dilution impact and approval timeline.*",
  "usage": {
    "prompt_tokens": 1777,
    "completion_tokens": 212,
    "total_tokens": 1989,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T23:58:51.403810"
}